Ginkgo Bioworks Holdings, Inc.

DNA · NYSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$561,572$944,073$1,315,792$1,550,004
Short-Term Investments$0$0$0$0
Receivables$22,443$17,899$84,026$149,899
Inventory$0$46$4,364$3,362
Other Curr. Assets$18,729$18,990$8,708$698
Total Curr. Assets$602,744$1,001,749$1,450,079$1,723,045
Property Plant & Equip (Net)$598,155$394,994$718,791$145,770
Goodwill$0$49,238$60,210$21,312
Intangibles$72,510$82,741$111,041$21,642
Long-Term Investments$48,704$77,911$111,794$115,231
Tax Assets$0$0$0$0
Other NC Assets$55,336$58,709$87,406$43,990
Total NC Assets$774,705$663,593$1,089,242$347,945
Other Assets$0$0$0$0
Total Assets$1,377,449$1,665,342$2,539,321$2,070,990
Liabilities
Payables$14,169$9,323$10,451$8,189
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$30,599$48,495$47,817$33,240
Other Curr. Liab.$26,621$54,381$52,505$40,314
Total Curr. Liab.$107,266$163,860$172,962$134,761
LT Debt$0$0$0$0
Deferred Rev, NC$98,783$158,062$174,767$155,991
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$16,576$24,433$42,059$190,576
Total NC Liab.$554,125$404,330$630,082$368,850
Other Liabilities$0$0$0$0
Cap. Leases$467,731$239,309$442,588$23,030
Total Liabilities$661,391$568,190$803,044$503,611
Equity
Pref Stock$0$0$0$0
Common Stock$5$5$190$161
Retained Earnings-$5,837,557-$5,290,528-$4,397,659-$2,297,925
AOCI-$1,806$1,484-$2,632-$1,715
Other Equity$0$0$0$0
Total Equity$716,058$1,097,152$1,736,277$1,505,365
Supplemental Information
Minority Interest$0$0$0$62,014
Total Liab. & Tot. Equity$1,377,449$1,665,342$2,539,321$2,070,990
Net Debt-$561,572-$944,073-$1,315,792-$1,550,004